1979
DOI: 10.1172/jci109614
|View full text |Cite
|
Sign up to set email alerts
|

Inhibition by propionyl-coenzyme A of N-acetylglutamate synthetase in rat liver mitochondria. A possible explanation for hyperammonemia in propionic and methylmalonic acidemia.

Abstract: A B S T R A C T In the search for the mechanism by which hyperammonemia complicates propionic and methylmalonic acidemia the effects of a series of acylcoenzyme A (CoA) derivatives were studied on the activity of N-acetylglutamate synthetase in rat liver mitochondria using acetyl-CoA as substrate. PropionylCoA was found to be a competitive inhibitor. The inhibition constant of 0.71 mM is in the range of concentrations ofpropionate found in the serum ofpatients with propionic and methylmalonic acidemia. Propion… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

5
94
0

Year Published

1982
1982
2021
2021

Publication Types

Select...
8
1
1

Relationship

0
10

Authors

Journals

citations
Cited by 199 publications
(99 citation statements)
references
References 36 publications
(28 reference statements)
5
94
0
Order By: Relevance
“…Notably, ureagenesis in methylmalonic and propionic aciduria is disturbed due to propionyl-CoA-induced inhibition of N-acetylglutamate synthetase, resulting in decreased N-acetylglutamate, the required allosteric activator of carbamoylphospate synthase I (46,47). In line with this, hyperammonemia is a frequent finding in methylmalonic aciduria (1).…”
Section: Discussionmentioning
confidence: 98%
“…Notably, ureagenesis in methylmalonic and propionic aciduria is disturbed due to propionyl-CoA-induced inhibition of N-acetylglutamate synthetase, resulting in decreased N-acetylglutamate, the required allosteric activator of carbamoylphospate synthase I (46,47). In line with this, hyperammonemia is a frequent finding in methylmalonic aciduria (1).…”
Section: Discussionmentioning
confidence: 98%
“…Factors known to be involved in the control of acetylglutamate synthetase activity are the intracellular levels of glutamate and acetyl-CoA [3], substrates, the concentrations of competitive inhibitors, such as propionyl-CoA [20], the hepatic content of arginine [3], a specific activator of the synthetase and the changes in sensitivity of the synthetase to arginine activation [ 191. It was also found [19] that cycloheximide injection, which inhibited the total protein synthesis in the mouse liver by 90070, did not inhibit the postprandial increase in arginine activation of the synthetase, thus indicating that the protein synthesis is not required for the change; actually cycloheximide stimulated the increase to a significant extent.…”
Section: Discussionmentioning
confidence: 99%
“…For instance, in propionic acidemia (PA), or a congenital deficiency of propionyl-CoA carboxylase, a decrease in NAG synthesis may occur either from competitive inhibition of NAGS by propionyl-CoA [29][30][31][32] or a relative depletion of hepatic acetyl-CoA or free coenzyme A [32]. Individual case reports suggest that NCG is helpful in the treatment of PA [33][34][35][36][37], but these are uncontrolled studies performed during an acute illness in which the effect of NCG is difficult to differentiate from that of standard care.…”
Section: Evaluating the Efficacy Of Therapeuticsmentioning
confidence: 99%